NCT03943498View on ClinicalTrials.gov

Fingolimod in Treating Patients With Chemotherapy-Induced Neuropathy

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

May 24, 2019

Primary Completion Date

December 10, 2020

Study Completion Date

December 10, 2020

Conditions
Chemotherapy-Induced Peripheral NeuropathyNumbnessPainTingling
Interventions
DRUG

Fingolimod

Given PO daily for 4 weeks

DRUG

Fingolimod Hydrochloride

Given PO

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (2)

43212

The Ohio State University, Columbus

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER